OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)
A Randomized, Double-masked, Study to Evaluate the Efficacy and Safety of OTX-DED (Dexamethasone Intracanalicular Ophthalmic Insert) for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Contact
Study Contact
- Name: Clinical Project Manager
- Phone Number: 781-357-4000
- Email: clinicalaffairs@ocutx.com
Study Locations
-
-
Tennessee
-
Memphis, Tennessee, United States, 38119
- Ocular Therapeutix
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- VAS eye dryness severity score ≥ 35 and ≤ 90 at screening.
- Investigator assessment of bulbar conjunctival hyperemia grade ≥ 2 (CCLRU; 0 - 4 scale).
- Unanesthetized Schirmer of > 0 and ≤ 10 mm.
- Must not have used Artificial Tears during the Screening period.
- IOP in both eyes ≥ 5 mmHg and ≤21 mmHg.
Exclusion Criteria:
- Have worn contact lenses in the 4 weeks prior to the screening visit and/or are unwilling to discontinue use of contact lenses throughout the study period.
- Have a history of glaucoma or ocular hypertension or have a history of intraocular pressure (IOP) < 5 mmHg or > 24 mmHg.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: OTX-DED 0.3mg
|
0.3mg dexamethasone ophthalmic insert
|
|
Experimental: Controlled Insertion utilizing Collagen Punctal Plug
|
Collagen Punctal Plug 0.2mm (Controlled Insertion)
|
|
Placebo Comparator: Collagen Punctal Plug (Full Insertion)
|
Collagen Punctal Plug 0.2mm (Full Insertion)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Severity of Eye Dryness Score (visual analogue scale (VAS))
Time Frame: Change from baseline (CFB) at Day 15
|
Visual Analogue Scale (0 mm - no discomfort to 100mm - maximal (the most) discomfort)
|
Change from baseline (CFB) at Day 15
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- OTX-DED-2022-C01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.